Sitagliptin
Top View
- File Download
- DPP-4 Inhibitors and Heart Failure
- Pre-Surgery Diabetes Medications
- Evaluation of Insulin Glargine in Combination with Sitagliptin in Type 2 Diabetes Patients: EASIE Extension Trial
- Janumet, INN-Sitagliptin/Metformin
- Merck Provides Update on Filing Plans for Omarigliptin, an Investigational DPP-4 Inhibitor for Type 2 Diabetes
- SUPPLEMENTARY DATA Supplementary
- (EXE) Or Sitagliptin (SITA) to Combination Therapy with Insulin Glargine (GLAR) and Metformin (MET) – a Proof-Of-Concept Study
- Insulin Therapy Management
- Rifamycins and Anti-Diabetic Agents: Drug-Drug Interactions
- Comparison of the Efficacy of Sitagliptin with Pioglitazone on Blood Glucose Control in Type 2 Diabetic Patients
- Januvia (Sitagliptin) Basics Powered by Lowers Your Blood Sugar
- Long-Term Efficacy of Glibenclamide and Sitagliptin Therapy in Adult
- Insulin and Combination Agents TCO 08.2020
- Clinical Study Report
- Janumet XR (Sitagliptin/Metformin Extended-Release)
- IRB00082180 NCT02556918 Sitagliptin for the Prevention and Treatment of Hyperglycemia in Patients with Type 2 Diabetes Undergoin
- Diabetes Management Medications